Highly sensitive AFP-L3% assay is useful for predicting recurrence of hepatocellular carcinoma after curative treatment pre- and postoperatively-Reference-Cited by-同舟云学术

Highly sensitive AFP-L3% assay is useful for predicting recurrence of hepatocellular carcinoma after curative treatment pre- and postoperatively

Published:2011-08-26 Issue:11 Volume:41 Page:1036-1045
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:

Author:

Kobayashi Masahiro,Hosaka Tetsuya,Ikeda Kenji,Seko Yuya,Kawamura Yusuke,Sezaki Hitomi,Akuta Norio,Suzuki Fumitaka,Suzuki Yoshiyuki,Saitoh Satoshi,Arase Yasuji,Kumada Hiromitsu

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1872-034X.2011.00858.x/fullpdf

Reference29 articles.

1. Cancer statistics, 2008;Jemal;CA Cancer J Clin,2008

2. Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma;Oka;Hepatology,1994

3. Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma;Daniele;Gastroenterology,2004

4. Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma;Marrero;Gastroenterology,2009

5. Diagnosis of hepatocellular carcinoma by concanavalin A affinity electrophoresis of serum alpha-fetoprotein;Saitoh;Cancer,1995

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Current Status of the Liver Liquid Biopsy in MASH Related HCC: Overview and Future Directions;Biomolecules;2023-09-09

2. Usefulness of Tumor Marker Score for Predicting the Prognosis of Hepatocellular Carcinoma Patients Treated with Atezolizumab Plus Bevacizumab: A Multicenter Retrospective Study;Cancers;2023-08-31

3. Dynamic changes in three biomarkers predict early-stage hepatocellular carcinoma in patients with chronic hepatitis B receiving antiviral therapy;Journal of Cancer Research and Clinical Oncology;2023-07-15

4. Capitalizing glycomic changes for improved biomarker-based cancer diagnostics;Exploration of Targeted Anti-tumor Therapy;2023-06-28

5. Consensus on the tertiary prevention of primary liver cancer;Hepatology International;2023-06-27